Share price: 112.80p

ADDITIONAL LISTING / TVR

17th April 2008

The Company announces that on 16 April 2008 it resolved to issue 5,650,026 new ordinary shares of 10p each to vendors and certain employees of the Group. These shares are to be issued as deferred consideration under the terms of the share purchase agreements with Insight Research Group Limited, Silvermills Group Limited, Tangible Communications Limited, Hill Murray Group Limited and Target Direct Holdings Limited, all wholly owned subsidiaries of the Company.

This issuance constitutes the settlement of all of the 2008 earn out liabilities that were detailed within the recent results announcement on 18 March 2008 when the Group announced its final results for the year ended 31 December 2007.

Application has been made for these shares to be admitted to trading on AIM and admission is expected to occur on 22 April 2008.

The Company’s issued share capital, following admission of the 5,650,026 deferred consideration shares, will be 44,561,603 ordinary shares of 10 pence each (“Ordinary Shares”), all with voting rights. The Company holds 80,000 Ordinary Shares in treasury at the date of this announcement. The total number of current voting rights in the Company will therefore be 44,481,603 shares.

The above figure (44,481,603 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FSA’s Disclosure and Transparency Rules.

 

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150